These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 8326698)

  • 1. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
    Heise HR; Vorwerk P; Fritsche K; Richter R
    Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
    Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M
    Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
    Lackner TE; Lau BW; Parvin C; Valdes R
    Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased digitalis-like immunoreactive substances in neonatal plasma measured using fluorescence polarization immunoassay.
    Ijiri Y; Hayahi T; Ogihara T; Ohi K; Suzuki K; Tamai H; Kitaura Y; Takenaka H; Tanaka K
    J Clin Pharm Ther; 2004 Dec; 29(6):565-71. PubMed ID: 15584945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interference of digoxin like immunoreactive substances with four recent reagents for digoxin determination].
    Marzullo C; Bourderont D; Dorr R
    Ann Biol Clin (Paris); 1996; 54(2):91-6. PubMed ID: 8763633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.
    Ng PK; LeGatt D; Coates J; Collins-Nakai RL
    Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
    Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
    Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
    Dasgupta A
    Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of the presence of digoxin-like immunoreactive substance (DLIS) in the serum and urine in children with nephrotic syndrome.
    Shimabukuro N; Ebara H; Maruyama K; Tomizawa S; Kuroume T
    Clin Nephrol; 1988 May; 29(5):244-7. PubMed ID: 2840225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous glycosides in critically ill patients.
    Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
    Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range.
    Morris RG; Jones TE; Goldsworthy SJ; Wagner TJ; Ho H; Horowitz JD
    Ther Drug Monit; 2006 Jun; 28(3):454-7. PubMed ID: 16778733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a Chinese medicine "kyushin" on serum digoxin concentration measurement in dogs.
    Lin CS; Lin MC; Chen KS; Liu CB
    Jpn Circ J; 1989 Feb; 53(2):108-12. PubMed ID: 2716172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay.
    Schlebusch H; Jarausch J; Domke I
    Wien Klin Wochenschr Suppl; 1992; 191():59-66. PubMed ID: 1509757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
    Li JH; Wu ZG; Xu JQ; Zhou Y
    Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant results from "real-world" patient samples assayed for digoxin.
    Jones TE; Morris RG
    Ann Pharmacother; 2008 Dec; 42(12):1797-803. PubMed ID: 19033482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale].
    Shi YS; Liu JH; Yu XZ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):229-31. PubMed ID: 8156846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the specificity of digoxin immunoassays.
    Valdes R
    Wien Klin Wochenschr Suppl; 1992; 191():55-9. PubMed ID: 1509756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
    Li J; Wu Z; Xu J; Zhou Y; Chu X
    Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency.
    Clerico A; Balzan S; Del Chicca MG; Paci A; Cocci F; Bertelli A
    Drugs Exp Clin Res; 1988; 14(9):603-7. PubMed ID: 3229323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.